Cargando…
New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma
SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma is the second most common primary liver malignancy after hepatocellular carcinoma and accounts for 20% of biliary tract cancers. The incidence of biliary tract cancer has been increasing in recent years, and many patients with biliary tract cancer are...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417782/ https://www.ncbi.nlm.nih.gov/pubmed/37568808 http://dx.doi.org/10.3390/cancers15153993 |